Latest Headlines

  1. Project Farma Acquires SimoTech To Expand Life Sciences Manufacturing Services 8/12/2026

    Project Farma, PerkinElmer's leading provider of Good Manufacturing Practice (GMP) manufacturing services, today announced it has entered into a definitive agreement to acquire SimoTech, a trusted provider of manufacturing automation and GMP IT solutions to the life sciences industry.

  2. Bristol Myers Squibb Selects Houston For Major $2.3B Manufacturing Investment 8/11/2026

    Bristol Myers Squibb (NYSE:BMY) today announced the selection of Houston, Texas, as the site for a new, state-of-the-art multi-modal manufacturing campus, representing an approximately $2.3 billion investment designed to accelerate the delivery of next-generation medicines to patients. The campus, at Generation Park in Houston, will create nearly 500 skilled jobs and is designed to grow in scale, capability and workforce for decades to come.

  3. Harro Höfliger Expands European Footprint With New France Subsidiary 8/10/2026

    With a local team and expanded service capacities, the company is creating the conditions for even closer cooperation with its French customers.

  4. STERIS To Invest $600 Million To Build Center Of Excellence In North Carolina 8/6/2026

    STERIS plc today announced that it will be investing $600 million to build a formulated chemistries manufacturing and distribution Center of Excellence in North Carolina, near the Raleigh-Durham Research Triangle region. The facility will serve as a central hub to produce high-performance infection prevention and contamination control chemistries used across the Healthcare and Pharmaceutical industries.

  5. BeOne Committing $1 Billion+ To U.S. Drug Manufacturing Growth 8/4/2026

    BeOne Medicines, Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced a $300 million expansion of its flagship clinical and commercial-stage manufacturing and research and development center at the Princeton West Innovation Campus in Hopewell, New Jersey, bringing total U.S. manufacturing investment to more than $1 billion. The expansion will increase BeOne's production capacity to manufacture its medicines and is expected to create approximately 120 new full-time jobs. The investment supports the continued advancement of BeOne's deep oncology pipeline of more than 35 clinical and commercial-stage assets.

  6. Why GSK Is Investing £400 Million In Cambridge 8/4/2026

    GSK plc (LSE/NYSE: GSK) today announced plans to establish a major new global R&D centre in Cambridge, UK, as part of the company’s plan to accelerate its R&D pipeline. The new 300,000 square foot site, on the Cambridge Biomedical Campus in the heart of the UK’s life sciences “Golden Triangle,” will be home to GSK’s R&D operations in the UK and more than 1,000 GSK scientists.

  7. Virtual Pharma Expo Launches Searchable Six-Year Equipment Demo Archive Ahead Of September Solid Dosage Event 7/30/2026

    Virtual Pharma Expo has launched a redesigned website that gives pharmaceutical manufacturing teams one place to watch every past equipment demonstration and register for upcoming live events.

  8. ROSS 250-Gallon Retention Mixers Designed For High-Pressure Processing 7/29/2026
  9. New Carrying Straps Simplify Handling Of Meissner's 16 L CryoVault® Container 7/27/2026
  10. Natoli Engineering Announces Acquisition Of Scheu & Kniss 7/23/2026

    Natoli Engineering Company, Inc., a global leader in tablet compression tooling, replacement parts, tablet presses, and technical services, today announced the acquisition of Scheu & Kniss, a company with more than a century of experience providing tablet press replacement parts, turret manufacturing, machine rebuilding, and technical support to the pharmaceutical, nutraceutical, confectionery, and industrial tablet manufacturing industries.